Mackenzie Financial Corp Legend Biotech Corp Transaction History

Mackenzie Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$55.06 - $69.99 $549,223 - $698,150	9,975 Added 6.53%	162,742 $9.13 Million
Q4 2023 Jan 30, 2024	BUY	$57.25 - $69.74 $1.36 Million - $1.66 Million	23,802 Added 18.46%	152,767 $9.19 Million
Q3 2023 Oct 25, 2023	BUY	$63.16 - $76.5 $7.56 Million - $9.15 Million	119,658 Added 1285.68%	128,965 $8.66 Million
Q2 2023 Aug 03, 2023	BUY	$46.28 - $75.01 $430,727 - $698,118	9,307 New	9,307 $642,000
Q3 2022 Oct 07, 2022	BUY	$38.15 - $57.1 $1.66 Million - $2.49 Million	43,561 Added 33.9%	172,049 $7.02 Million
Q2 2022 Aug 10, 2022	BUY	$33.54 - $55.0 $4.31 Million - $7.07 Million	128,488 New	128,488 $7.07 Million
Q1 2022 May 13, 2022	SELL	$31.02 - $48.18 $729,218 - $1.13 Million	-23,508 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $967,119 - $1.34 Million	23,508 New	23,508 $1.1 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.5B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.